Granules India Limited (NSE:GRANULES)
India · Delayed Price · Currency is INR 845.00
+19.30 (2.34%)
Aug 5, 2026, 3:30 PM IST
Granules India Market Cap
Granules India has a market cap or net worth of 209.24 billion as of August 5, 2026. Its market cap has increased by 89.73% in one year.
Market Cap
209.24B
Enterprise Value
215.02B
Revenue
56.32B
Ranking
n/a
PE Ratio
31.59
Stock Price
845.00
ChartMarket Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 209.24B, an increase of 127,718.94%. That is a compound annual growth rate of 35.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 209.24B | 44.06% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gland Pharma | 412.37B |
| Emcure Pharmaceuticals | 371.61B |
| Wockhardt | 318.44B |
| Piramal Pharma | 259.61B |
| Eris Lifesciences | 187.72B |
| NATCO Pharma | 164.24B |
| Cohance Lifesciences | 162.61B |
| Alembic Pharmaceuticals | 156.67B |